19152507_1|19152507|85|#section_info|662:892|NADPH-dependent consumption of NO localized to cell membranes and was inhibited by proteinase K, indicating the involvement of a membrane-bound protein. Purification of this activity yielded CYPOR (cytochrome P450 oxidoreductase).|#main_body|GO:0016020|membrane|#go_definition|NONE|GOA|Por(29441)|#gene_synonym
0.67	19152507_107|19152507|16926|RESULTS|0:0|Incubation of synaptosome or glial membranes with proteinase K degraded all protein and abolished NADPH-dependent NO consumption (Figure 1E), indicating that a protein is required.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19152507_125|19152507|19976|RESULTS|0:0|The NADPH-binding properties of CYPOR made it a good candidate for mediating NADPH-dependent NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19152507_151|19152507|25391|RESULTS|0:0|The compounds (200 muM) did not affect CYPOR activity in the presence of Trolox (results not shown) but they both concentration-dependently reduced NADPH-dependent NO consumption by brain membranes (Figure 3D), suggesting that one or more cytochrome P450s may be involved.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.59	19152507_104|19152507|16926|RESULTS|0:0|NADPH-dependent NO consumption localized to the membrane fraction following high-speed centrifugation of lysed glia (Figures 1B and 1C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.59	19152507_123|19152507|19976|RESULTS|0:0|Solubilization of brain membranes with 3 mM dodecylmaltoside preserved NADPH-dependent NO consumption (but see below), allowing purification of this activity by chromatography (see the Materials and methods section).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.59	19152507_155|19152507|26329|DISCUSSION|0:0|Interestingly, NO has been shown to bind and inhibit several cytochrome P450s [31,32], making them intriguing candidates for NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.58	19152507_85|19152507|13494|RESULTS|0:0|NO inactivation by glia requires NADPH and is dependent on a membrane protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.57	19152507_94|19152507|13572|RESULTS|0:0|(E) NO levels following addition of 100 muM DETA/NO and 100 muM NADPH to synaptosome and glial membranes at 1 mg of protein/ml before and after incubation at 37  C for 30 min+-0.5 mg/ml proteinase K. NADPH decreased NO levels in controls but not in proteinase K-treated membranes (P=0.20; glial membranes: n=8; synaptosome membranes n=3).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.56	19152507_74|19152507|11584|MATERIALS AND METHODS|0:0|The CYPOR activity of membranes was determined by comparison to the rate of cytochrome c reduction by purified CYPOR standards (Sigma).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.56	19152507_100|19152507|16054|RESULTS|0:0|NO inactivation depends on a membrane-bound flavoprotein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.56	19152507_138|19152507|23580|RESULTS|0:0|In the case of purified CYPOR, NADPH reduced the NO concentration (and therefore increased NO consumption) only when DTPA and Trolox were present, whereas DTPA and Trolox had no effect on NADPH-dependent NO consumption by brain membranes.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_108|19152507|16926|RESULTS|0:0|It seems, therefore, that brain membranes possess a flavin-dependent protein that is involved in NO consumption.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.52	19152507_128|19152507|20768|RESULTS|0:0|We quantified the CYPOR activity in membranes of glia, whole brain, and several other cell types, by measuring the rate of reduction of cytochrome c. The CYPOR content of the different cell types correlated with the NO consumption activity, expressed as the change in NO on application of NADPH as a percentage of the NO plateau after DETA/NO addition (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.52	19152507_145|19152507|23580|RESULTS|0:0|(D) The decrease in NO concentration on the addition of NADPH to brain membranes (2 mg/ml) plus 300 muM DETA/NO was reduced by the cytochrome P450 inhibitors clotrimazole (squares) and ketaconazole (circles).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_53|19152507|8610|MATERIALS AND METHODS|0:0|Membrane and cytosolic fractions were prepared by centrifugation at 53000 rev./min using a TLA-100.2 rotor (Beckman Instruments) for 1 h. The supernatant was retained and membranes were resuspended in incubation buffer by sonication.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_129|19152507|20768|RESULTS|0:0|Cell types previously found to have no detectable NO-consuming activity when intact (platelets and white blood cells; [18]) also showed no NADPH-dependent NO consumption by their membranes, and had a low CYPOR content.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_87|19152507|13572|RESULTS|0:0|(B) Representative traces of NO accumulation following sequential applications of 100 muM DETA/NO (at t=0) and 100 muM NADPH (open arrows) to buffer, glial lysate and, following centrifugation at 53000 rev./min using a TLA-100.2 rotor for 1 h, cytosolic supernatant plus membrane pellet, the membrane pellet and supernatant alone.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_130|19152507|20768|RESULTS|0:0|A breast cancer cell line (T47D) showed some NO consumption when intact, even at a very low cell density (0.06 mg/ml protein; plateau NO=82% of that in buffer, P=0.018 compared with buffer, n=6), and also demonstrated NADPH-dependent membrane consumption and some CYPOR content (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_132|19152507|21848|RESULTS|0:0|Anti-CYPOR antibodies inhibit NO consumption by brain membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_171|19152507|29351|DISCUSSION|0:0|Before pursuing it further, the physiological relevance of this process to that observed in brain membranes and intact cells needs to be clarified, bearing in mind that the lack of Trolox-dependence in brain membranes indicates that the Trolox effect may be an artifact.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.49	19152507_131|19152507|20768|RESULTS|0:0|NO consumption by intact T47D cells and by their membranes was higher when CYPOR was constitutively overexpressed (Figure 2A; plateau NO in intact cells=43% of buffer, P<0.0001 compared with buffer, n=6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.49	19152507_159|19152507|27841|DISCUSSION|0:0|The sensitivity of brain membranes to imidazole-derived cytochrome P450 inhibitors suggests that the operative cytochrome P450 is not likely to be CYPs 3A4, 2A6 or 2C19, which are much more sensitive to ketaconazole and clotrimazole [26].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.48	19152507_15|19152507|3359|INTRODUCTION|0:0|A process with similar properties [membrane localization and NAD(P)H dependence] has also been reported in cultured endothelial cells [16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_57|19152507|8980|MATERIALS AND METHODS|0:0|Crude membranes were prepared by centrifugation of homogenate at 5 mg protein/ml at 53000 rev./min using a TLA-100.2 rotor for 1 h. To prepare a purer preparation, homogenates were centrifuged for 1 h at 50000 g, the supernatant discarded and the membranes resuspended and centrifuged for a further 1 h at 50000 g, before final resuspension in 25 mM Tris/HCl, pH 7.45, at ~10 mg/ml protein.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_61|19152507|9751|MATERIALS AND METHODS|0:0|Forebrain membranes (0.8 mg/ml protein) were solubilized by gentle agitation for 1 h at 4  C in buffer containing 25 mM Tris/HCl, pH 7.45, 100 mM KCl, 10% (v/v) glycerol and 3 mM dodecyl maltoside (Calbiochem, Nottingham, U.K.).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_110|19152507|17637|RESULTS|0:0|(A) 300 muM DETA/NO was added to membranes from different cell types (as labelled) in cell incubation buffer, with DTPA but no Trolox.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_137|19152507|23580|RESULTS|0:0|(A) Plateau NO concentrations following application of NADPH to 300 muM DETA/NO and purified CYPOR (100 m-units/ml) or brain membranes (2 mg of protein/ml)+-DTPA and Trolox (both 100 muM).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_105|19152507|16926|RESULTS|0:0|Membranes from forebrain synaptosomes and whole brain homogenates also both exhibited a similar NADPH-dependent NO consumption (Figure 1D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_120|19152507|17637|RESULTS|0:0|(D) NO concentration reached after sequential additions of 100 muM DETA/NO, 100 muM NADPH and 50 muM DPI to synaptosome membranes (1 mg protein/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_92|19152507|13572|RESULTS|0:0|(D) Summary of results when 100 muM DETA/NO and 100 muM NADPH were added to membranes from glia, synaptosomes and whole brain (all at 1 mg/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_118|19152507|17637|RESULTS|0:0|(C) NO concentration reached after 100 muM DETA/NO addition to brain membranes at 1 mg of protein/ml, following incubation for 2 h on ice with control buffer, 0.33 mg/ml of gamma-IgG or 0.33 mg/ml of alpha-CYPOR, before (open bars) and after (solid bars) addition of 100 muM NADPH.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_91|19152507|13572|RESULTS|0:0|Buffer and cytosol are not significantly different from each other, but were different from the membrane pellet, resuspended lysate and control lysate (repeated measures using ANOVA with Tukey post hoc tests, P<0.001; n=4).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.41	19152507_56|19152507|8980|MATERIALS AND METHODS|0:0|Membranes from forebrains from 8-12-day-old Sprague-Dawley rat pups were homogenized in 25 mM Tris/HCl, pH 7.45 using an Ultraturrax homogenizer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.41	19152507_65|19152507|9751|MATERIALS AND METHODS|0:0|Solubilized membranes (150 ml) were loaded onto 4x5 ml columns and the protein was eluted with a gradient of 100-500 mM KCl over 200 min, with a flow rate of 1 ml/min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_54|19152507|8610|MATERIALS AND METHODS|0:0|Protein concentrations of membranes refer to the concentration of protein in the pre-spun sample.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_59|19152507|8980|MATERIALS AND METHODS|0:0|Membranes were then stored at -80  C for later use.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.33	19152507_55|19152507|8942|MATERIALS AND METHODS|0:0|Whole brain homogenates and membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19152507_3|19152507|85|#section_info|893:1053|Antibodies against CYPOR inhibited NO consumption by brain membranes and the amount of CYPOR in several cell types correlated with their rate of NO consumption.|#main_body|GO:0016020|membrane|#go_definition|IDA|GOA|Por(29441)|#gene_synonym
0.74	19152507_132|19152507|21848|RESULTS|0:0|Anti-CYPOR antibodies inhibit NO consumption by brain membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19152507_128|19152507|20768|RESULTS|0:0|We quantified the CYPOR activity in membranes of glia, whole brain, and several other cell types, by measuring the rate of reduction of cytochrome c. The CYPOR content of the different cell types correlated with the NO consumption activity, expressed as the change in NO on application of NADPH as a percentage of the NO plateau after DETA/NO addition (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19152507_138|19152507|23580|RESULTS|0:0|In the case of purified CYPOR, NADPH reduced the NO concentration (and therefore increased NO consumption) only when DTPA and Trolox were present, whereas DTPA and Trolox had no effect on NADPH-dependent NO consumption by brain membranes.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19152507_125|19152507|19976|RESULTS|0:0|The NADPH-binding properties of CYPOR made it a good candidate for mediating NADPH-dependent NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19152507_129|19152507|20768|RESULTS|0:0|Cell types previously found to have no detectable NO-consuming activity when intact (platelets and white blood cells; [18]) also showed no NADPH-dependent NO consumption by their membranes, and had a low CYPOR content.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19152507_155|19152507|26329|DISCUSSION|0:0|Interestingly, NO has been shown to bind and inhibit several cytochrome P450s [31,32], making them intriguing candidates for NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.59	19152507_151|19152507|25391|RESULTS|0:0|The compounds (200 muM) did not affect CYPOR activity in the presence of Trolox (results not shown) but they both concentration-dependently reduced NADPH-dependent NO consumption by brain membranes (Figure 3D), suggesting that one or more cytochrome P450s may be involved.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.56	19152507_108|19152507|16926|RESULTS|0:0|It seems, therefore, that brain membranes possess a flavin-dependent protein that is involved in NO consumption.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.55	19152507_131|19152507|20768|RESULTS|0:0|NO consumption by intact T47D cells and by their membranes was higher when CYPOR was constitutively overexpressed (Figure 2A; plateau NO in intact cells=43% of buffer, P<0.0001 compared with buffer, n=6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_107|19152507|16926|RESULTS|0:0|Incubation of synaptosome or glial membranes with proteinase K degraded all protein and abolished NADPH-dependent NO consumption (Figure 1E), indicating that a protein is required.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_130|19152507|20768|RESULTS|0:0|A breast cancer cell line (T47D) showed some NO consumption when intact, even at a very low cell density (0.06 mg/ml protein; plateau NO=82% of that in buffer, P=0.018 compared with buffer, n=6), and also demonstrated NADPH-dependent membrane consumption and some CYPOR content (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_171|19152507|29351|DISCUSSION|0:0|Before pursuing it further, the physiological relevance of this process to that observed in brain membranes and intact cells needs to be clarified, bearing in mind that the lack of Trolox-dependence in brain membranes indicates that the Trolox effect may be an artifact.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_105|19152507|16926|RESULTS|0:0|Membranes from forebrain synaptosomes and whole brain homogenates also both exhibited a similar NADPH-dependent NO consumption (Figure 1D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_145|19152507|23580|RESULTS|0:0|(D) The decrease in NO concentration on the addition of NADPH to brain membranes (2 mg/ml) plus 300 muM DETA/NO was reduced by the cytochrome P450 inhibitors clotrimazole (squares) and ketaconazole (circles).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_123|19152507|19976|RESULTS|0:0|Solubilization of brain membranes with 3 mM dodecylmaltoside preserved NADPH-dependent NO consumption (but see below), allowing purification of this activity by chromatography (see the Materials and methods section).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.48	19152507_104|19152507|16926|RESULTS|0:0|NADPH-dependent NO consumption localized to the membrane fraction following high-speed centrifugation of lysed glia (Figures 1B and 1C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_74|19152507|11584|MATERIALS AND METHODS|0:0|The CYPOR activity of membranes was determined by comparison to the rate of cytochrome c reduction by purified CYPOR standards (Sigma).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_85|19152507|13494|RESULTS|0:0|NO inactivation by glia requires NADPH and is dependent on a membrane protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_110|19152507|17637|RESULTS|0:0|(A) 300 muM DETA/NO was added to membranes from different cell types (as labelled) in cell incubation buffer, with DTPA but no Trolox.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_94|19152507|13572|RESULTS|0:0|(E) NO levels following addition of 100 muM DETA/NO and 100 muM NADPH to synaptosome and glial membranes at 1 mg of protein/ml before and after incubation at 37  C for 30 min+-0.5 mg/ml proteinase K. NADPH decreased NO levels in controls but not in proteinase K-treated membranes (P=0.20; glial membranes: n=8; synaptosome membranes n=3).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_137|19152507|23580|RESULTS|0:0|(A) Plateau NO concentrations following application of NADPH to 300 muM DETA/NO and purified CYPOR (100 m-units/ml) or brain membranes (2 mg of protein/ml)+-DTPA and Trolox (both 100 muM).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_118|19152507|17637|RESULTS|0:0|(C) NO concentration reached after 100 muM DETA/NO addition to brain membranes at 1 mg of protein/ml, following incubation for 2 h on ice with control buffer, 0.33 mg/ml of gamma-IgG or 0.33 mg/ml of alpha-CYPOR, before (open bars) and after (solid bars) addition of 100 muM NADPH.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_87|19152507|13572|RESULTS|0:0|(B) Representative traces of NO accumulation following sequential applications of 100 muM DETA/NO (at t=0) and 100 muM NADPH (open arrows) to buffer, glial lysate and, following centrifugation at 53000 rev./min using a TLA-100.2 rotor for 1 h, cytosolic supernatant plus membrane pellet, the membrane pellet and supernatant alone.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_92|19152507|13572|RESULTS|0:0|(D) Summary of results when 100 muM DETA/NO and 100 muM NADPH were added to membranes from glia, synaptosomes and whole brain (all at 1 mg/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_159|19152507|27841|DISCUSSION|0:0|The sensitivity of brain membranes to imidazole-derived cytochrome P450 inhibitors suggests that the operative cytochrome P450 is not likely to be CYPs 3A4, 2A6 or 2C19, which are much more sensitive to ketaconazole and clotrimazole [26].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.42	19152507_15|19152507|3359|INTRODUCTION|0:0|A process with similar properties [membrane localization and NAD(P)H dependence] has also been reported in cultured endothelial cells [16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_100|19152507|16054|RESULTS|0:0|NO inactivation depends on a membrane-bound flavoprotein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_120|19152507|17637|RESULTS|0:0|(D) NO concentration reached after sequential additions of 100 muM DETA/NO, 100 muM NADPH and 50 muM DPI to synaptosome membranes (1 mg protein/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.38	19152507_53|19152507|8610|MATERIALS AND METHODS|0:0|Membrane and cytosolic fractions were prepared by centrifugation at 53000 rev./min using a TLA-100.2 rotor (Beckman Instruments) for 1 h. The supernatant was retained and membranes were resuspended in incubation buffer by sonication.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.38	19152507_54|19152507|8610|MATERIALS AND METHODS|0:0|Protein concentrations of membranes refer to the concentration of protein in the pre-spun sample.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_57|19152507|8980|MATERIALS AND METHODS|0:0|Crude membranes were prepared by centrifugation of homogenate at 5 mg protein/ml at 53000 rev./min using a TLA-100.2 rotor for 1 h. To prepare a purer preparation, homogenates were centrifuged for 1 h at 50000 g, the supernatant discarded and the membranes resuspended and centrifuged for a further 1 h at 50000 g, before final resuspension in 25 mM Tris/HCl, pH 7.45, at ~10 mg/ml protein.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_61|19152507|9751|MATERIALS AND METHODS|0:0|Forebrain membranes (0.8 mg/ml protein) were solubilized by gentle agitation for 1 h at 4  C in buffer containing 25 mM Tris/HCl, pH 7.45, 100 mM KCl, 10% (v/v) glycerol and 3 mM dodecyl maltoside (Calbiochem, Nottingham, U.K.).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_55|19152507|8942|MATERIALS AND METHODS|0:0|Whole brain homogenates and membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_65|19152507|9751|MATERIALS AND METHODS|0:0|Solubilized membranes (150 ml) were loaded onto 4x5 ml columns and the protein was eluted with a gradient of 100-500 mM KCl over 200 min, with a flow rate of 1 ml/min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_91|19152507|13572|RESULTS|0:0|Buffer and cytosol are not significantly different from each other, but were different from the membrane pellet, resuspended lysate and control lysate (repeated measures using ANOVA with Tukey post hoc tests, P<0.001; n=4).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.34	19152507_56|19152507|8980|MATERIALS AND METHODS|0:0|Membranes from forebrains from 8-12-day-old Sprague-Dawley rat pups were homogenized in 25 mM Tris/HCl, pH 7.45 using an Ultraturrax homogenizer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.3	19152507_59|19152507|8980|MATERIALS AND METHODS|0:0|Membranes were then stored at -80  C for later use.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19152507_10|19152507|24711|#section_info|371:494|Solubilized membranes in the presence of Trolox could then be further purified to yield purified CYPOR, as described above.|#main_body|GO:0016020|membrane|#go_definition|IDA|GOA|Por(29441)|#gene_synonym
0.58	19152507_123|19152507|19976|RESULTS|0:0|Solubilization of brain membranes with 3 mM dodecylmaltoside preserved NADPH-dependent NO consumption (but see below), allowing purification of this activity by chromatography (see the Materials and methods section).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.57	19152507_74|19152507|11584|MATERIALS AND METHODS|0:0|The CYPOR activity of membranes was determined by comparison to the rate of cytochrome c reduction by purified CYPOR standards (Sigma).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_53|19152507|8610|MATERIALS AND METHODS|0:0|Membrane and cytosolic fractions were prepared by centrifugation at 53000 rev./min using a TLA-100.2 rotor (Beckman Instruments) for 1 h. The supernatant was retained and membranes were resuspended in incubation buffer by sonication.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_57|19152507|8980|MATERIALS AND METHODS|0:0|Crude membranes were prepared by centrifugation of homogenate at 5 mg protein/ml at 53000 rev./min using a TLA-100.2 rotor for 1 h. To prepare a purer preparation, homogenates were centrifuged for 1 h at 50000 g, the supernatant discarded and the membranes resuspended and centrifuged for a further 1 h at 50000 g, before final resuspension in 25 mM Tris/HCl, pH 7.45, at ~10 mg/ml protein.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_61|19152507|9751|MATERIALS AND METHODS|0:0|Forebrain membranes (0.8 mg/ml protein) were solubilized by gentle agitation for 1 h at 4  C in buffer containing 25 mM Tris/HCl, pH 7.45, 100 mM KCl, 10% (v/v) glycerol and 3 mM dodecyl maltoside (Calbiochem, Nottingham, U.K.).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_137|19152507|23580|RESULTS|0:0|(A) Plateau NO concentrations following application of NADPH to 300 muM DETA/NO and purified CYPOR (100 m-units/ml) or brain membranes (2 mg of protein/ml)+-DTPA and Trolox (both 100 muM).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_138|19152507|23580|RESULTS|0:0|In the case of purified CYPOR, NADPH reduced the NO concentration (and therefore increased NO consumption) only when DTPA and Trolox were present, whereas DTPA and Trolox had no effect on NADPH-dependent NO consumption by brain membranes.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.48	19152507_107|19152507|16926|RESULTS|0:0|Incubation of synaptosome or glial membranes with proteinase K degraded all protein and abolished NADPH-dependent NO consumption (Figure 1E), indicating that a protein is required.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.48	19152507_171|19152507|29351|DISCUSSION|0:0|Before pursuing it further, the physiological relevance of this process to that observed in brain membranes and intact cells needs to be clarified, bearing in mind that the lack of Trolox-dependence in brain membranes indicates that the Trolox effect may be an artifact.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_110|19152507|17637|RESULTS|0:0|(A) 300 muM DETA/NO was added to membranes from different cell types (as labelled) in cell incubation buffer, with DTPA but no Trolox.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_151|19152507|25391|RESULTS|0:0|The compounds (200 muM) did not affect CYPOR activity in the presence of Trolox (results not shown) but they both concentration-dependently reduced NADPH-dependent NO consumption by brain membranes (Figure 3D), suggesting that one or more cytochrome P450s may be involved.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_65|19152507|9751|MATERIALS AND METHODS|0:0|Solubilized membranes (150 ml) were loaded onto 4x5 ml columns and the protein was eluted with a gradient of 100-500 mM KCl over 200 min, with a flow rate of 1 ml/min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_94|19152507|13572|RESULTS|0:0|(E) NO levels following addition of 100 muM DETA/NO and 100 muM NADPH to synaptosome and glial membranes at 1 mg of protein/ml before and after incubation at 37  C for 30 min+-0.5 mg/ml proteinase K. NADPH decreased NO levels in controls but not in proteinase K-treated membranes (P=0.20; glial membranes: n=8; synaptosome membranes n=3).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_87|19152507|13572|RESULTS|0:0|(B) Representative traces of NO accumulation following sequential applications of 100 muM DETA/NO (at t=0) and 100 muM NADPH (open arrows) to buffer, glial lysate and, following centrifugation at 53000 rev./min using a TLA-100.2 rotor for 1 h, cytosolic supernatant plus membrane pellet, the membrane pellet and supernatant alone.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_130|19152507|20768|RESULTS|0:0|A breast cancer cell line (T47D) showed some NO consumption when intact, even at a very low cell density (0.06 mg/ml protein; plateau NO=82% of that in buffer, P=0.018 compared with buffer, n=6), and also demonstrated NADPH-dependent membrane consumption and some CYPOR content (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.42	19152507_125|19152507|19976|RESULTS|0:0|The NADPH-binding properties of CYPOR made it a good candidate for mediating NADPH-dependent NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.41	19152507_59|19152507|8980|MATERIALS AND METHODS|0:0|Membranes were then stored at -80  C for later use.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_54|19152507|8610|MATERIALS AND METHODS|0:0|Protein concentrations of membranes refer to the concentration of protein in the pre-spun sample.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_56|19152507|8980|MATERIALS AND METHODS|0:0|Membranes from forebrains from 8-12-day-old Sprague-Dawley rat pups were homogenized in 25 mM Tris/HCl, pH 7.45 using an Ultraturrax homogenizer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_104|19152507|16926|RESULTS|0:0|NADPH-dependent NO consumption localized to the membrane fraction following high-speed centrifugation of lysed glia (Figures 1B and 1C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_129|19152507|20768|RESULTS|0:0|Cell types previously found to have no detectable NO-consuming activity when intact (platelets and white blood cells; [18]) also showed no NADPH-dependent NO consumption by their membranes, and had a low CYPOR content.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.4	19152507_155|19152507|26329|DISCUSSION|0:0|Interestingly, NO has been shown to bind and inhibit several cytochrome P450s [31,32], making them intriguing candidates for NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.39	19152507_15|19152507|3359|INTRODUCTION|0:0|A process with similar properties [membrane localization and NAD(P)H dependence] has also been reported in cultured endothelial cells [16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.39	19152507_91|19152507|13572|RESULTS|0:0|Buffer and cytosol are not significantly different from each other, but were different from the membrane pellet, resuspended lysate and control lysate (repeated measures using ANOVA with Tukey post hoc tests, P<0.001; n=4).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.39	19152507_118|19152507|17637|RESULTS|0:0|(C) NO concentration reached after 100 muM DETA/NO addition to brain membranes at 1 mg of protein/ml, following incubation for 2 h on ice with control buffer, 0.33 mg/ml of gamma-IgG or 0.33 mg/ml of alpha-CYPOR, before (open bars) and after (solid bars) addition of 100 muM NADPH.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_120|19152507|17637|RESULTS|0:0|(D) NO concentration reached after sequential additions of 100 muM DETA/NO, 100 muM NADPH and 50 muM DPI to synaptosome membranes (1 mg protein/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_128|19152507|20768|RESULTS|0:0|We quantified the CYPOR activity in membranes of glia, whole brain, and several other cell types, by measuring the rate of reduction of cytochrome c. The CYPOR content of the different cell types correlated with the NO consumption activity, expressed as the change in NO on application of NADPH as a percentage of the NO plateau after DETA/NO addition (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_131|19152507|20768|RESULTS|0:0|NO consumption by intact T47D cells and by their membranes was higher when CYPOR was constitutively overexpressed (Figure 2A; plateau NO in intact cells=43% of buffer, P<0.0001 compared with buffer, n=6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.36	19152507_105|19152507|16926|RESULTS|0:0|Membranes from forebrain synaptosomes and whole brain homogenates also both exhibited a similar NADPH-dependent NO consumption (Figure 1D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_85|19152507|13494|RESULTS|0:0|NO inactivation by glia requires NADPH and is dependent on a membrane protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_92|19152507|13572|RESULTS|0:0|(D) Summary of results when 100 muM DETA/NO and 100 muM NADPH were added to membranes from glia, synaptosomes and whole brain (all at 1 mg/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.35	19152507_145|19152507|23580|RESULTS|0:0|(D) The decrease in NO concentration on the addition of NADPH to brain membranes (2 mg/ml) plus 300 muM DETA/NO was reduced by the cytochrome P450 inhibitors clotrimazole (squares) and ketaconazole (circles).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.34	19152507_108|19152507|16926|RESULTS|0:0|It seems, therefore, that brain membranes possess a flavin-dependent protein that is involved in NO consumption.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.33	19152507_100|19152507|16054|RESULTS|0:0|NO inactivation depends on a membrane-bound flavoprotein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.33	19152507_132|19152507|21848|RESULTS|0:0|Anti-CYPOR antibodies inhibit NO consumption by brain membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.32	19152507_55|19152507|8942|MATERIALS AND METHODS|0:0|Whole brain homogenates and membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.26	19152507_159|19152507|27841|DISCUSSION|0:0|The sensitivity of brain membranes to imidazole-derived cytochrome P450 inhibitors suggests that the operative cytochrome P450 is not likely to be CYPs 3A4, 2A6 or 2C19, which are much more sensitive to ketaconazole and clotrimazole [26].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19152507_12|19152507|25919|#section_info|0:133|In this study we present evidence that brain cells consume NO by a membrane-localized process that involves NADPH oxidation by CYPOR,|#main_body|GO:0016020|membrane|#go_definition|NONE|GOA|Por(29441)|#gene_synonym
0.58	19152507_128|19152507|20768|RESULTS|0:0|We quantified the CYPOR activity in membranes of glia, whole brain, and several other cell types, by measuring the rate of reduction of cytochrome c. The CYPOR content of the different cell types correlated with the NO consumption activity, expressed as the change in NO on application of NADPH as a percentage of the NO plateau after DETA/NO addition (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.57	19152507_138|19152507|23580|RESULTS|0:0|In the case of purified CYPOR, NADPH reduced the NO concentration (and therefore increased NO consumption) only when DTPA and Trolox were present, whereas DTPA and Trolox had no effect on NADPH-dependent NO consumption by brain membranes.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.57	19152507_151|19152507|25391|RESULTS|0:0|The compounds (200 muM) did not affect CYPOR activity in the presence of Trolox (results not shown) but they both concentration-dependently reduced NADPH-dependent NO consumption by brain membranes (Figure 3D), suggesting that one or more cytochrome P450s may be involved.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.56	19152507_85|19152507|13494|RESULTS|0:0|NO inactivation by glia requires NADPH and is dependent on a membrane protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_108|19152507|16926|RESULTS|0:0|It seems, therefore, that brain membranes possess a flavin-dependent protein that is involved in NO consumption.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.53	19152507_125|19152507|19976|RESULTS|0:0|The NADPH-binding properties of CYPOR made it a good candidate for mediating NADPH-dependent NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_107|19152507|16926|RESULTS|0:0|Incubation of synaptosome or glial membranes with proteinase K degraded all protein and abolished NADPH-dependent NO consumption (Figure 1E), indicating that a protein is required.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_129|19152507|20768|RESULTS|0:0|Cell types previously found to have no detectable NO-consuming activity when intact (platelets and white blood cells; [18]) also showed no NADPH-dependent NO consumption by their membranes, and had a low CYPOR content.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.51	19152507_145|19152507|23580|RESULTS|0:0|(D) The decrease in NO concentration on the addition of NADPH to brain membranes (2 mg/ml) plus 300 muM DETA/NO was reduced by the cytochrome P450 inhibitors clotrimazole (squares) and ketaconazole (circles).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.5	19152507_155|19152507|26329|DISCUSSION|0:0|Interestingly, NO has been shown to bind and inhibit several cytochrome P450s [31,32], making them intriguing candidates for NO consumption by brain membranes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.49	19152507_171|19152507|29351|DISCUSSION|0:0|Before pursuing it further, the physiological relevance of this process to that observed in brain membranes and intact cells needs to be clarified, bearing in mind that the lack of Trolox-dependence in brain membranes indicates that the Trolox effect may be an artifact.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.48	19152507_94|19152507|13572|RESULTS|0:0|(E) NO levels following addition of 100 muM DETA/NO and 100 muM NADPH to synaptosome and glial membranes at 1 mg of protein/ml before and after incubation at 37  C for 30 min+-0.5 mg/ml proteinase K. NADPH decreased NO levels in controls but not in proteinase K-treated membranes (P=0.20; glial membranes: n=8; synaptosome membranes n=3).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_87|19152507|13572|RESULTS|0:0|(B) Representative traces of NO accumulation following sequential applications of 100 muM DETA/NO (at t=0) and 100 muM NADPH (open arrows) to buffer, glial lysate and, following centrifugation at 53000 rev./min using a TLA-100.2 rotor for 1 h, cytosolic supernatant plus membrane pellet, the membrane pellet and supernatant alone.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.47	19152507_130|19152507|20768|RESULTS|0:0|A breast cancer cell line (T47D) showed some NO consumption when intact, even at a very low cell density (0.06 mg/ml protein; plateau NO=82% of that in buffer, P=0.018 compared with buffer, n=6), and also demonstrated NADPH-dependent membrane consumption and some CYPOR content (Figure 2A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_120|19152507|17637|RESULTS|0:0|(D) NO concentration reached after sequential additions of 100 muM DETA/NO, 100 muM NADPH and 50 muM DPI to synaptosome membranes (1 mg protein/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.46	19152507_137|19152507|23580|RESULTS|0:0|(A) Plateau NO concentrations following application of NADPH to 300 muM DETA/NO and purified CYPOR (100 m-units/ml) or brain membranes (2 mg of protein/ml)+-DTPA and Trolox (both 100 muM).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_15|19152507|3359|INTRODUCTION|0:0|A process with similar properties [membrane localization and NAD(P)H dependence] has also been reported in cultured endothelial cells [16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_100|19152507|16054|RESULTS|0:0|NO inactivation depends on a membrane-bound flavoprotein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_105|19152507|16926|RESULTS|0:0|Membranes from forebrain synaptosomes and whole brain homogenates also both exhibited a similar NADPH-dependent NO consumption (Figure 1D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_123|19152507|19976|RESULTS|0:0|Solubilization of brain membranes with 3 mM dodecylmaltoside preserved NADPH-dependent NO consumption (but see below), allowing purification of this activity by chromatography (see the Materials and methods section).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.45	19152507_131|19152507|20768|RESULTS|0:0|NO consumption by intact T47D cells and by their membranes was higher when CYPOR was constitutively overexpressed (Figure 2A; plateau NO in intact cells=43% of buffer, P<0.0001 compared with buffer, n=6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_74|19152507|11584|MATERIALS AND METHODS|0:0|The CYPOR activity of membranes was determined by comparison to the rate of cytochrome c reduction by purified CYPOR standards (Sigma).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.44	19152507_92|19152507|13572|RESULTS|0:0|(D) Summary of results when 100 muM DETA/NO and 100 muM NADPH were added to membranes from glia, synaptosomes and whole brain (all at 1 mg/ml).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_104|19152507|16926|RESULTS|0:0|NADPH-dependent NO consumption localized to the membrane fraction following high-speed centrifugation of lysed glia (Figures 1B and 1C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_118|19152507|17637|RESULTS|0:0|(C) NO concentration reached after 100 muM DETA/NO addition to brain membranes at 1 mg of protein/ml, following incubation for 2 h on ice with control buffer, 0.33 mg/ml of gamma-IgG or 0.33 mg/ml of alpha-CYPOR, before (open bars) and after (solid bars) addition of 100 muM NADPH.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.43	19152507_132|19152507|21848|RESULTS|0:0|Anti-CYPOR antibodies inhibit NO consumption by brain membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.41	19152507_110|19152507|17637|RESULTS|0:0|(A) 300 muM DETA/NO was added to membranes from different cell types (as labelled) in cell incubation buffer, with DTPA but no Trolox.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.41	19152507_159|19152507|27841|DISCUSSION|0:0|The sensitivity of brain membranes to imidazole-derived cytochrome P450 inhibitors suggests that the operative cytochrome P450 is not likely to be CYPs 3A4, 2A6 or 2C19, which are much more sensitive to ketaconazole and clotrimazole [26].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.38	19152507_53|19152507|8610|MATERIALS AND METHODS|0:0|Membrane and cytosolic fractions were prepared by centrifugation at 53000 rev./min using a TLA-100.2 rotor (Beckman Instruments) for 1 h. The supernatant was retained and membranes were resuspended in incubation buffer by sonication.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_57|19152507|8980|MATERIALS AND METHODS|0:0|Crude membranes were prepared by centrifugation of homogenate at 5 mg protein/ml at 53000 rev./min using a TLA-100.2 rotor for 1 h. To prepare a purer preparation, homogenates were centrifuged for 1 h at 50000 g, the supernatant discarded and the membranes resuspended and centrifuged for a further 1 h at 50000 g, before final resuspension in 25 mM Tris/HCl, pH 7.45, at ~10 mg/ml protein.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.37	19152507_61|19152507|9751|MATERIALS AND METHODS|0:0|Forebrain membranes (0.8 mg/ml protein) were solubilized by gentle agitation for 1 h at 4  C in buffer containing 25 mM Tris/HCl, pH 7.45, 100 mM KCl, 10% (v/v) glycerol and 3 mM dodecyl maltoside (Calbiochem, Nottingham, U.K.).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.34	19152507_56|19152507|8980|MATERIALS AND METHODS|0:0|Membranes from forebrains from 8-12-day-old Sprague-Dawley rat pups were homogenized in 25 mM Tris/HCl, pH 7.45 using an Ultraturrax homogenizer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.33	19152507_54|19152507|8610|MATERIALS AND METHODS|0:0|Protein concentrations of membranes refer to the concentration of protein in the pre-spun sample.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.32	19152507_91|19152507|13572|RESULTS|0:0|Buffer and cytosol are not significantly different from each other, but were different from the membrane pellet, resuspended lysate and control lysate (repeated measures using ANOVA with Tukey post hoc tests, P<0.001; n=4).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.31	19152507_65|19152507|9751|MATERIALS AND METHODS|0:0|Solubilized membranes (150 ml) were loaded onto 4x5 ml columns and the protein was eluted with a gradient of 100-500 mM KCl over 200 min, with a flow rate of 1 ml/min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.3	19152507_55|19152507|8942|MATERIALS AND METHODS|0:0|Whole brain homogenates and membranes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.26	19152507_59|19152507|8980|MATERIALS AND METHODS|0:0|Membranes were then stored at -80  C for later use.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
